טוען...
Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library
Lyme disease is a leading vector-borne disease in the United States. Although the majority of Lyme patients can be cured with standard 2–4 week antibiotic treatment, 10%–20% of patients continue to suffer from prolonged post-treatment Lyme disease syndrome (PTLDS). While the cause for this is unclea...
שמור ב:
| הוצא לאור ב: | Antibiotics (Basel) |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4790293/ https://ncbi.nlm.nih.gov/pubmed/27025631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics4030397 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|